214 related articles for article (PubMed ID: 32927671)
21. Molecular characterization of endometrial cancer and therapeutic implications.
Uppendahl L; Mullany SA; Winterhoff B
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):35-39. PubMed ID: 27941362
[TBL] [Abstract][Full Text] [Related]
22. Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma.
Britton H; Huang L; Lum A; Leung S; Shum K; Kale M; Burleigh A; Senz J; Yang W; McConechy M; Kommoss S; Brucker S; Talhouk A; Gilks CB; McAlpine JN
Gynecol Oncol; 2019 Jun; 153(3):487-495. PubMed ID: 30922603
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment.
Nero C; Ciccarone F; Pietragalla A; Duranti S; Daniele G; Scambia G; Lorusso D
Front Oncol; 2021; 11():612450. PubMed ID: 34540651
[TBL] [Abstract][Full Text] [Related]
24. Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.
Nebot-Bral L; Brandao D; Verlingue L; Rouleau E; Caron O; Despras E; El-Dakdouki Y; Champiat S; Aoufouchi S; Leary A; Marabelle A; Malka D; Chaput N; Kannouche PL
Eur J Cancer; 2017 Oct; 84():290-303. PubMed ID: 28846956
[TBL] [Abstract][Full Text] [Related]
25. The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer.
Jamieson A; Bosse T; McAlpine JN
Ther Adv Med Oncol; 2021; 13():17588359211035959. PubMed ID: 34408794
[TBL] [Abstract][Full Text] [Related]
26. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Stelloo E; Nout RA; Osse EM; Jürgenliemk-Schulz IJ; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Nijman HW; Putter H; Bosse T; Creutzberg CL; Smit VT
Clin Cancer Res; 2016 Aug; 22(16):4215-24. PubMed ID: 27006490
[TBL] [Abstract][Full Text] [Related]
27. [Current prerequisites for a molecular genetic classification of endometrial cancer].
Vtorushin SV; Malykh RD
Arkh Patol; 2017; 79(3):57-62. PubMed ID: 28631718
[TBL] [Abstract][Full Text] [Related]
28. Molecular insights into the classification of high-grade endometrial carcinoma.
Hussein YR; Soslow RA
Pathology; 2018 Feb; 50(2):151-161. PubMed ID: 29246451
[TBL] [Abstract][Full Text] [Related]
29. L1CAM: amending the "low-risk" category in endometrial carcinoma.
Kommoss F; Kommoss F; Grevenkamp F; Bunz AK; Taran FA; Fend F; Brucker SY; Wallwiener D; Schönfisch B; Greif K; Lax S; Staebler A; Kommoss S
J Cancer Res Clin Oncol; 2017 Feb; 143(2):255-262. PubMed ID: 27695947
[TBL] [Abstract][Full Text] [Related]
30. Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
Jamieson A; Barroilhet LM; McAlpine JN
Cancer; 2022 Aug; 128(15):2853-2857. PubMed ID: 35657171
[TBL] [Abstract][Full Text] [Related]
31. Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management.
Abdulfatah E; Wakeling E; Sakr S; Al-Obaidy K; Bandyopadhyay S; Morris R; Feldman G; Ali-Fehmi R
Gynecol Oncol; 2019 Sep; 154(3):467-474. PubMed ID: 31248668
[TBL] [Abstract][Full Text] [Related]
32. Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma.
Depreeuw J; Stelloo E; Osse EM; Creutzberg CL; Nout RA; Moisse M; Garcia-Dios DA; Dewaele M; Willekens K; Marine JC; Matias-Guiu X; Amant F; Lambrechts D; Bosse T
Clin Cancer Res; 2017 Dec; 23(23):7232-7241. PubMed ID: 28939739
[No Abstract] [Full Text] [Related]
33. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
Kommoss S; McConechy MK; Kommoss F; Leung S; Bunz A; Magrill J; Britton H; Kommoss F; Grevenkamp F; Karnezis A; Yang W; Lum A; Krämer B; Taran F; Staebler A; Lax S; Brucker SY; Huntsman DG; Gilks CB; McAlpine JN; Talhouk A
Ann Oncol; 2018 May; 29(5):1180-1188. PubMed ID: 29432521
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathological classification of colorectal cancer.
Müller MF; Ibrahim AE; Arends MJ
Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
[TBL] [Abstract][Full Text] [Related]
35. Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives.
Giustozzi A; Salutari V; Giudice E; Musacchio L; Ricci C; Landolfo C; Perri MT; Scambia G; Lorusso D
Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571723
[TBL] [Abstract][Full Text] [Related]
36. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.
Iijima M; Banno K; Okawa R; Yanokura M; Iida M; Takeda T; Kunitomi-Irie H; Adachi M; Nakamura K; Umene K; Nogami Y; Masuda K; Tominaga E; Aoki D
Oncol Lett; 2017 Mar; 13(3):1063-1070. PubMed ID: 28454214
[TBL] [Abstract][Full Text] [Related]
38. Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma.
Talhouk A; Derocher H; Schmidt P; Leung S; Milne K; Gilks CB; Anglesio MS; Nelson BH; McAlpine JN
Clin Cancer Res; 2019 Apr; 25(8):2537-2548. PubMed ID: 30523022
[TBL] [Abstract][Full Text] [Related]
39. [Clinical application of TCGA molecular classification in endometrial endometrioid carcinoma].
Du NN; Liu Y; Ren CX; Wang YX; Du J; Yang J; Liu CR
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):596-603. PubMed ID: 31422589
[No Abstract] [Full Text] [Related]
40. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.
Karnezis AN; Leung S; Magrill J; McConechy MK; Yang W; Chow C; Kobel M; Lee CH; Huntsman DG; Talhouk A; Kommoss F; Gilks CB; McAlpine JN
J Pathol Clin Res; 2017 Oct; 3(4):279-293. PubMed ID: 29085668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]